Reduxbio
1 known investors
Find your way into Reduxbio
Sign up to see every warm intro you have to Reduxbio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Reduxbio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Redux Bio develops bio-based vaccines and biological solutions for animal health and aquaculture, including fish and other livestock products. The company focuses on early discovery, development, and scale-up of vaccines and industrial biotech products for the animal health industry.
Founders & leadership
LT
Lincoln TubbsCEO
RK

TD

Board
MA
Miguel Angelo De Facci de OliveiraActive Director
AS

Investors · 1
Genoa Ventureslisted by Genoa VenturesSan Francisco
How we know: Genoa Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
Related companies · 3
bioBIO is the world's largest advocacy association representing biotechnology companies and research institutions across the United States and 30+ other nations. The organization facilitates industry networking through events, conferences, and partnering software while providing cost-savings programs and advocacy services for member companies.
Response PharmaceuticalsResponse Pharmaceuticals is a clinical-stage drug developer working on RDX-002, a small-molecule iMTP inhibitor for weight management and metabolic health, including post-GLP-1 receptor agonist weight management and antipsychotic-induced weight gain. The company is advancing the candidate through Phase 2 clinical trials.
Aro BiotherapeuticsAro Biotherapeutics develops tissue-targeted genetic medicines using a proprietary protein technology called Centyrins. The company builds a wholly-owned pipeline of Centyrin-based therapeutic candidates and partners with industry to enable tissue-specific targeting of therapeutics across a range of diseases.
Companies working in the same space as Reduxbio.
Frequently asked questions
- What does Reduxbio do?
- Redux Bio develops bio-based vaccines and biological solutions for animal health and aquaculture, including fish and other livestock products. The company focuses on early discovery, development, and scale-up of vaccines and industrial biotech products for the animal health industry.
- Who are Reduxbio's investors?
- Reduxbio's investors include Genoa Ventures.


